N02.5
Recurrent and persistent hematuria with diffuse mesangiocapillary glomerulonephritis
Clinical Classification Guidelines
Inclusion Terms
- Recurrent and persistent hematuria with membranoproliferative glomerulonephritis, types 1 and 3, or NOS
Excludes Type 1
- Recurrent and persistent hematuria with C3 glomerulonephritis (N02.A)
- Recurrent and persistent hematuria with C3 glomerulopathy (N02.A)
Medical Intelligence & Overview
ICD-10 code N02.5 refers to a kidney condition characterized by recurrent and persistent blood in the urine, known as hematuria. This condition is associated with diffuse mesangiocapillary glomerulonephritis, a specific type of kidney inflammation affecting the tiny filtering units of the kidneys called glomeruli. This form of glomerulonephritis includes types 1 and 3, and is often part of a broader group known as membranoproliferative glomerulonephritis. Understanding this condition involves exploring its causes, symptoms, diagnosis, and management to better grasp its impact on kidney health.
Causes & Symptoms
Clinical Causes: Autoimmune reactions where the body's immune system attacks kidney tissues Chronic infections such as hepatitis C or bacterial endocarditis Related systemic diseases like lupus erythematosus Certain immune complex depositions leading to kidney inflammation Genetic predispositions in some cases Unknown factors in some instances (NOS—Not Otherwise Specified)
Key Symptoms: Persistent blood in the urine, often visible as pink or cola-colored urine Swelling in the ankles, feet, or around the eyes due to fluid retention Dark or cloudy urine indicating ongoing hematuria High blood pressure Reduced urine output in advanced stages Signs of urine protein loss such as foamy urine
Diagnostic & Treatment
Diagnosis Path: Diagnosis of diffuse mesangiocapillary glomerulonephritis with hematuria involves multiple steps, including: - Urinalysis to detect blood and protein in the urine - Blood tests to assess kidney function and immune markers - Kidney biopsy to analyze tissue samples under a microscope, confirming the pattern of glomerular damage - Imaging tests, like ultrasound, to evaluate kidney size and structure These procedures help distinguish this condition from other types of glomerulonephritis and determine the severity of kidney involvement.
Treatment Protocols: While specific medical management depends on the individual case and severity, common approaches include: - Use of medications to control blood pressure, such as ACE inhibitors or ARBs, which may also help reduce proteinuria - Immunosuppressive therapies to modulate immune system activity if an autoimmune component is identified - Diuretics to manage edema and fluid overload - Dietary modifications to support kidney health, including salt and protein intake regulation - Regular monitoring of kidney function and urine analysis In some scenarios, advanced cases may require procedures like dialysis or kidney transplantation. A tailored treatment plan is essential to manage symptoms and slow disease progression.
Clinical Advice & FAQs
Billing Guidance
Is N02.5 a billable ICD-10 code?
Yes, N02.5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report N02.5?
Clinical documentation must specify the nature of Recurrent and persistent hematuria with diffuse mesangiocapillary glomerulonephritis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
